Standard BioTools Inc (LAB)
2.40
-0.01
(-0.41%)
USD |
NASDAQ |
May 10, 16:00
2.405
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Total Assets (Quarterly): 323.07M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 323.07M |
| September 30, 2023 | 339.28M |
| June 30, 2023 | 355.83M |
| March 31, 2023 | 371.65M |
| December 31, 2022 | 390.31M |
| September 30, 2022 | 414.92M |
| June 30, 2022 | 441.12M |
| March 31, 2022 | 271.94M |
| December 31, 2021 | 275.21M |
| September 30, 2021 | 282.19M |
| June 30, 2021 | 289.32M |
| March 31, 2021 | 305.20M |
| December 31, 2020 | 324.76M |
| September 30, 2020 | 322.98M |
| June 30, 2020 | 282.35M |
| March 31, 2020 | 290.22M |
| December 31, 2019 | 264.81M |
| September 30, 2019 | 269.39M |
| June 30, 2019 | 283.79M |
| March 31, 2019 | 291.45M |
| December 31, 2018 | 303.65M |
| September 30, 2018 | 252.29M |
| June 30, 2018 | 259.10M |
| March 31, 2018 | 269.70M |
| December 31, 2017 | 287.35M |
| Date | Value |
|---|---|
| September 30, 2017 | 292.00M |
| June 30, 2017 | 278.71M |
| March 31, 2017 | 292.47M |
| December 31, 2016 | 306.40M |
| September 30, 2016 | 320.42M |
| June 30, 2016 | 342.03M |
| March 31, 2016 | 354.44M |
| December 31, 2015 | 370.05M |
| September 30, 2015 | 378.49M |
| June 30, 2015 | 389.13M |
| March 31, 2015 | 395.03M |
| December 31, 2014 | 407.56M |
| September 30, 2014 | 410.39M |
| June 30, 2014 | 417.75M |
| March 31, 2014 | 424.72M |
| December 31, 2013 | 116.92M |
| September 30, 2013 | 114.24M |
| June 30, 2013 | 111.96M |
| March 31, 2013 | 113.24M |
| December 31, 2012 | 113.73M |
| September 30, 2012 | 117.10M |
| June 30, 2012 | 64.93M |
| March 31, 2012 | 70.67M |
| December 31, 2011 | 79.33M |
| September 30, 2011 | 82.60M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
264.81M
Minimum
Dec 2019
441.12M
Maximum
Jun 2022
320.96M
Average
305.20M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| Bruker Corp | 4.506B |
| Azenta Inc | 2.563B |
| Harvard Bioscience Inc | 133.16M |
| Bionano Genomics Inc | 158.00M |
| Akoya Biosciences Inc | 180.37M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 471.12M |
| Shareholders Equity (Quarterly) | -148.05M |
| Debt to Equity Ratio | -0.429 |
| Current Ratio | 1.447 |
| Net Debt Paydown Yield | 0.14% |